[ET Net News Agency, 2 December 2020] Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
(02196) said its controlling shareholder, Shanghai Fosun High Technology (Group) Company
Limited yesterday acquired 1.37 million H shares at an average purchase price of HK$33.97
per share.
The aggregate number of shares purchased represents 0.25% of the total number of H
shares in issue, and 0.05% of the total issued shares of the company.
The total purchase price is RMB39.57 million. Prior to the shareholding increase, Fosun
High Tech held 38.54% of the total issued shares of the company. After the purchase, its
stake increased to 38.59%.
Fosun High Tech intends to further increase its shareholding in the company within the
12-month period. The cumulative total consideration shall not be less than RMB100 million
and the additional shareholding interest to be acquired shall not exceed 2% of the total
issued shares of the company. (KL)